2019
DOI: 10.1111/jcmm.14267
|View full text |Cite
|
Sign up to set email alerts
|

Raddeanin A down‐regulates androgen receptor and its splice variants in prostate cancer

Abstract: Castration‐resistant progression of prostate cancer is a major cause of prostate cancer mortality, and increased expression and activity of the full‐length and the splice variants of androgen receptor (AR) have been indicated to drive castration resistance. Consequently, there is an urgent need to develop agents that can target both the full‐length and the splice variants of AR for more effective treatment of prostate cancer. In the present study, we showed that raddeanin A (RA), an oleanane‐type triterpenoid … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
13
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(13 citation statements)
references
References 56 publications
(128 reference statements)
0
13
0
Order By: Relevance
“…Due to the side effects of chemotherapy and radiography, the use of traditional Chinese medicine has become widely accepted as an effective method to treat cancers. Being an oleanane-type triterpenoid saponin extracted from the root of Anemone raddeana Regel, RA displays a promising anti-tumor effect on malignant tumors, including endometrial cancer and prostate cancer [ 25 , 26 ]. Compelling evidence indicates that RA inhibits the invasion, migration, adhesion and induces apoptosis of human gastric cancer cells, exhibiting potential to become an antitumor drug [ 9 ].…”
Section: Discussionmentioning
confidence: 99%
“…Due to the side effects of chemotherapy and radiography, the use of traditional Chinese medicine has become widely accepted as an effective method to treat cancers. Being an oleanane-type triterpenoid saponin extracted from the root of Anemone raddeana Regel, RA displays a promising anti-tumor effect on malignant tumors, including endometrial cancer and prostate cancer [ 25 , 26 ]. Compelling evidence indicates that RA inhibits the invasion, migration, adhesion and induces apoptosis of human gastric cancer cells, exhibiting potential to become an antitumor drug [ 9 ].…”
Section: Discussionmentioning
confidence: 99%
“…It promotes proteasome-mediated degradation and inhibition of androgen receptor (AR) gene transcription. It has been reported to promote the growth-inhibitory effect of docetaxel, a drug used in prostate cancer chemotherapy (17). Bone metastasis is a serious complication of advanced breast cancer, resulting in osteolysis and increased mortality.…”
Section: Discussionmentioning
confidence: 99%
“…5-FU is the most common chemotherapeutic compound for cancer treatment [69]. RA sensitized cholangiocarcinoma cell lines to 5-FU treatment and ameliorated 5-FU resistance in bile duct cancer cells through activating multiple cell cycle and apoptosis-related factors, such as COX-2, Bax, Bcl-2, and cyclins E/D1 [136]. RA may also have the potential to enhance the growth inhibitory efficacy of docetaxel, the first-line chemotherapy for prostate cancer [137].…”
Section: Chemosensitizing Properties Of Ramentioning
confidence: 99%
“…RA may also have the potential to enhance the growth inhibitory efficacy of docetaxel, the first-line chemotherapy for prostate cancer [137]. The growth and survival of prostate cancer cells rely on androgen receptor (AR) [136]. Splice variants of AR (AR-V) expression have been proposed to be a mechanism of docetaxel resistance.…”
Section: Chemosensitizing Properties Of Ramentioning
confidence: 99%